Mokam Life Science Institute and Ewha Womans University Join Hands for AI Drug Development Research

Mokam Life Science Research Institute announced on the 15th that it has signed a memorandum of understanding (MOU) for collaborative research on new drug development using artificial intelligence (AI) algorithms with Ewha Womans University. The signing ceremony was held on the afternoon of the 13th at the Mokam Research Institute in Seocho-gu, Seoul, attended by Director Kim Seon, Deputy Director Shin Hyunjin, and Professor Choi Seon from Ewha Womans University College of Pharmacy.

Director Kim Seon of Mokam Life Science Research Institute (left) and Professor Choi Seon of Ewha Womans University College of Pharmacy are posing for a commemorative photo at the signing ceremony of a business agreement for collaborative research on new drug development using AI algorithms.
[Photo by Mokam Life Science Research Institute]

Through this agreement, both parties plan to strengthen cooperation in the field of AI-based new drug development based on their respective research capabilities, presenting a model case of collaboration between academia and industry. Since transforming into an AI-based new drug development research institute in 2022, Mokam Research Institute has been conducting research on new drug development for various modalities, including messenger ribonucleic acid (mRNA) therapeutics.

The company explained that since Professor Choi Seon's team has been recognized for outstanding research achievements in areas such as the three-dimensional structure and dynamics of target proteins, the synergy of AI technology cooperation between the two institutions for new drug development is expected to be significant.

Director Kim Seon of Mokam Research Institute said, "This agreement will further expand the foundation of AI research for new drug development at Mokam Research Institute," adding, "We will continuously communicate with Professor Choi Seon's research team to achieve practical research outcomes." Professor Choi Seon also stated, "Based on past research achievements, we will conduct extensive research with Mokam Research Institute to contribute to new drug development and related industries."

This content was produced with the assistance of AI translation services.